메뉴 건너뛰기




Volumn 27, Issue 1, 2001, Pages

Immunological therapy of sepsis: Experimental therapies

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; COMPLEMENT; CYCLOOXYGENASE 2; CYTOKINE; ENDOTOXIN; FIBRINOGEN; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN P55; PROTEIN P75; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

EID: 0034915322     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000574     Document Type: Article
Times cited : (66)

References (119)
  • 1
    • 0030982989 scopus 로고    scopus 로고
    • Therapies for sepsis. Emerging therapies for sepsis and septic shock
    • (1997) West J Med , vol.166 , pp. 195-200
    • Abraham, E.1
  • 26
    • 0030951146 scopus 로고    scopus 로고
    • p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β
    • (1997) J Biol Chem , vol.272 , pp. 8083-8089
    • Guan, Z.1    Baier, L.D.2    Morrison, A.R.3
  • 28
    • 0029979369 scopus 로고    scopus 로고
    • Biological basis for interleukin-1 in disease
    • (1996) Blood , vol.87 , pp. 2095-2147
    • Dinarello, C.A.1
  • 47
    • 0026780301 scopus 로고
    • Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: A prospective double-blind study
    • (1992) J Infect Dis , vol.165 , pp. 695-701
  • 48
    • 0026016470 scopus 로고
    • Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind placebo-controlled trial
    • (1991) N Engl J Med , vol.324 , pp. 429-436
  • 67
    • 0028957549 scopus 로고
    • Monoclonal antibody to human tumor necrosis factor alpha (TNF MAb): Efficacy and safety in patients with the sepsis syndrome
    • (1995) JAMA , vol.273 , pp. 934-941
    • Abraham, E.1    Wunderink, R.2    Silverman, H.3
  • 68
    • 0029835023 scopus 로고    scopus 로고
    • INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis
    • (1996) Crit Care Med , vol.24 , pp. 1431-1440
    • Cohen, J.1    Carlet, J.2
  • 70
    • 9344246862 scopus 로고    scopus 로고
    • Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study
    • (1996) Crit Care Med , vol.24 , pp. 733-742
    • Reinhart, K.1    Wiegand-Lohnert, C.2    Grimminger, F.3
  • 72
    • 8244235133 scopus 로고    scopus 로고
    • p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock
    • (1997) JAMA , vol.277 , pp. 1531-1534
    • Abraham, E.1    Glauser, M.P.2    Butler, T.3
  • 75
    • 0021708124 scopus 로고
    • 2 levels: Correlation with the hemodynamic and pulmonary changes in gram-negative septic shock
    • (1984) J Lab Clin Med , vol.104 , pp. 873-881
    • Vadas, P.1
  • 91
    • 0030926515 scopus 로고    scopus 로고
    • Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14
    • (1997) Blood , vol.89 , pp. 4268-4274
    • Park, T.1    Creasey, A.2    Wright, S.3
  • 103
    • 0026710191 scopus 로고
    • ACCP/SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
    • (1992) Chest , vol.101 , pp. 1644-1655
    • Bone, R.C.1    Balk, R.A.2    Cerra, F.B.3
  • 113
    • 0008021312 scopus 로고    scopus 로고
    • Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, Deltibant (CP-0127)
    • (1997) JAMA , vol.277 , pp. 482-487
    • Fein, A.M.1    Bernard, G.R.2    Criner, G.J.3
  • 115
  • 116
    • 0032433468 scopus 로고    scopus 로고
    • Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized double-blind, placebo-controlled, multicenter clinical trial
    • (1998) Crit Care Med , vol.26 , pp. 1963-1971
    • Dhainaut, J.F.1    Tenaillon, A.2    Hemmer, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.